1. Home
  2. MLAB vs IDR Comparison

MLAB vs IDR Comparison

Compare MLAB & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLAB
  • IDR
  • Stock Information
  • Founded
  • MLAB 1982
  • IDR 1996
  • Country
  • MLAB United States
  • IDR United States
  • Employees
  • MLAB N/A
  • IDR N/A
  • Industry
  • MLAB Industrial Machinery/Components
  • IDR Precious Metals
  • Sector
  • MLAB Industrials
  • IDR Basic Materials
  • Exchange
  • MLAB Nasdaq
  • IDR Nasdaq
  • Market Cap
  • MLAB 341.1M
  • IDR 378.0M
  • IPO Year
  • MLAB N/A
  • IDR N/A
  • Fundamental
  • Price
  • MLAB $65.15
  • IDR $28.89
  • Analyst Decision
  • MLAB Buy
  • IDR Strong Buy
  • Analyst Count
  • MLAB 2
  • IDR 1
  • Target Price
  • MLAB $113.50
  • IDR $17.50
  • AVG Volume (30 Days)
  • MLAB 126.2K
  • IDR 426.7K
  • Earning Date
  • MLAB 11-06-2025
  • IDR 11-03-2025
  • Dividend Yield
  • MLAB 0.99%
  • IDR N/A
  • EPS Growth
  • MLAB N/A
  • IDR 57.55
  • EPS
  • MLAB N/A
  • IDR 0.64
  • Revenue
  • MLAB $242,351,000.00
  • IDR $30,496,328.00
  • Revenue This Year
  • MLAB $5.38
  • IDR $21.91
  • Revenue Next Year
  • MLAB $5.25
  • IDR $5.47
  • P/E Ratio
  • MLAB N/A
  • IDR $45.25
  • Revenue Growth
  • MLAB 8.33
  • IDR 59.64
  • 52 Week Low
  • MLAB $55.45
  • IDR $9.67
  • 52 Week High
  • MLAB $155.12
  • IDR $32.01
  • Technical
  • Relative Strength Index (RSI)
  • MLAB 47.20
  • IDR 59.64
  • Support Level
  • MLAB $58.83
  • IDR $27.85
  • Resistance Level
  • MLAB $67.91
  • IDR $32.01
  • Average True Range (ATR)
  • MLAB 3.73
  • IDR 1.98
  • MACD
  • MLAB 0.55
  • IDR -0.20
  • Stochastic Oscillator
  • MLAB 64.16
  • IDR 43.45

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About IDR Idaho Strategic Resources Inc.

Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.

Share on Social Networks: